Results 261 to 270 of about 554,589 (315)

The early treatment of Parkinson's disease: levodopa, dopamine agonists or both

, 2000
M. B. Stern
openalex   +1 more source

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Preclinical studies suggest that highly selective dopamine D3 receptor (D3R) antagonists or partial agonists hold promise for treating substance use disorders. However, their limited effectiveness in reducing cocaine self‐administration is a major drawback.
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, Guo‐Hua Bi, Emily Linz, Caleb D. Vogt, Emma S. Gogarnoiu, Lei Shi, Amy Hauck Newman, Zheng‐Xiong Xi   +9 more
wiley   +1 more source

Treatment of social phobia with the dopamine agonist pergolide

, 2000
Gerardo Villarreal, Mike Johnson, Robert N. Rubey, R. Bruce Lydiard, James C. Ballanger   +4 more
openalex   +1 more source

Relevance of state–behaviour feedbacks for animal welfare

Biological Reviews, EarlyView.
ABSTRACT An animal's behaviour and its state, including its health and affective state, are dynamic and tightly coupled, influencing each other over time. Although both are relevant to the animal's welfare, there has been limited research on their dynamics in welfare studies. Here we aim to: (i) review evidence for feedbacks between state and behaviour
Camille M. Montalcini, Charles C. Driver, Michael T. Mendl   +2 more
wiley   +1 more source

Feedback inhibition of dopamine synthesis by continuous administration of dopamine agonists

, 2000
Shin-ichi Iwata, Masahiro Nomoto, Shun Kaseda, Takeo Fududa   +3 more
openalex   +1 more source

Dopamine agonist resistant prolactinomas: any alternative medical treatment? [PDF]

Pituitary, 2020
Souteiro P, Karavitaki N.
europepmc   +1 more source

Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D₁-Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement [PDF]

, 2004
Sophia T. Papadeas, Bonita L. Blake, Darin J. Knapp, George R. Breese   +3 more
openalex   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen, Anja H. Brunsveld‐Reinders, Nienke R. Biermasz, Marco J. T. Verstegen, Eline Leijtens, Wilco C. Peul, Ewout W. Steyerberg, Wouter R. van Furth   +7 more
wiley   +1 more source